Physician profile
Arthur Brinckerhoff
NPI 1023049624
$508.18
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $122.74 | 2019 | |
| Novo Nordisk INC | $64.88 | 2019 | |
| Sunovion Pharmaceuticals INC. | $49.66 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.95 | 2019 | |
| Lilly USA, LLC | $27.58 | 2019 | |
| Sanofi-Aventis U.S. LLC | $27.10 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.00 | 2019 | |
| Allergan, INC. | $25.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.92 | 2019 | |
| Sanofi Pasteur INC. | $19.30 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.59 | 2019 | |
| Amarin Pharma, INC. | $15.33 | 2019 | |
| Merck Sharp & Dohme LLC | $13.86 | 2019 | |
| Amgen INC. | $12.04 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $11.62 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $11.37 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Brinckerhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.